Global Nasal Drug Delivery Devices Market Research Report
- Report Code: NA 1000
- Publish Date: Upcoming
The global nasal drug delivery market, mainly driven by high prevalence of cardiovascular diseases, cancer, and diabetes, rising demand for home healthcare devices, and increased focus on pediatric and elderly patients, was valued at $9.94 billion in 2013, and expected to be $15.02 billion by 2018, at a CAGR of 8.60%.
The report ‘Global Nasal Drug Delivery Market forecast, 2012-2018’ analyzes the market by segments such as nasal drops, nasal spray, nasal inhalers, and other nasal drug delivery technologies.
Globally, North America is the largest market for nasal drug delivery application, and is followed by Europe and Asia-Pacific. Developing countries of Asia, the Middle East, and Latin America are expected to witness high market growth due to developments in the economy, improved healthcare infrastructure, escalating penetration of medical insurances, and growing incidences of chronic diseases.
Other factors driving this market include rapid research and development and adoption of new drug delivery technologies and devices, fast onset of action and reformulation of oral drugs and injections into the formulations to be administered by nasal route. However, drug formulation failure and market recalls, and technical barrier may pose a challenge to the growth of this market.
The report also provides an extensive competitive landscaping of companies operating in the nasal drug delivery market, namely 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, and Kurve Technology, Inc.
Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options
Along with the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of cardiovascular diseases, cancer, and diabetes
- Country-specific patient pool of cardiovascular diseases, cancer, and diabetes
- Disease progression (pattern analysis)
Pharmacists Forum
- Fast turn-around analysis of pharmacists’ response to market events and trends
- Pharmacists’ opinion about products from different companies
- Pharmacists’ qualitative inputs on epidemiology data
- Pattern analysis of usage of drugs by physicians
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Competitive Intelligence
- Company share analysis of the top players in the market in different countries
- Crucial developments and strategies of companies inculcated in their portfolio
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Nasal Drops Submarkets of this market are Drug Delivery Technology. Key Questions Answered What are market estimates and forecasts; which of Nasal Drops markets are doing well and which are not? What makes... |
Upcoming |
|
|
North American Nasal Drug Delivery Market The North American Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.49 billion in 2013 and expected to be $6.62 billion by 2018, growing at a CAGR of 8.1%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
European Nasal Drug Delivery Market The European Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.95 billion in 2013 and expected to be $4.14 billion by 2018, growing at a CAGR of 7.0%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
Asian Nasal Drug Delivery Market The Asian Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.51 billion in 2013 and expected to be $2.69 billion by 2018, growing at a CAGR of 12.2%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
